CDKN2A and breast cancer: Treatment of precancerous and breast cancer cells with GEN increased the expression of tumor suppressor genes p16INK4a (p16) and p21WAF1 (p21) through enrichment of transcriptional active markers such as acetyl-H3, acetyl-H4, and trimethyl-H3K4.